Status:

RECRUITING

Comparing Telehealth to In-person a Combined Metacognitive Training in Veterans With mTBI/PTSD

Lead Sponsor:

VA Office of Research and Development

Conditions:

Brain Injury

Cognition

Eligibility:

All Genders

30-55 years

Phase:

NA

Brief Summary

Veterans with mild traumatic brain injury (mTBI) and post-traumatic stress disorder (PTSD) commonly experience cognitive impairments including attention and executive function deficits that interfere ...

Detailed Description

Background. Over 70% of Veterans with mild traumatic brain injury (mTBI), seeking services at the Veterans' Health Administration, suffer from comorbid post-traumatic stress disorder (PTSD). These Vet...

Eligibility Criteria

Inclusion

  • Veterans who have served in OIF-OEF-OND and have been diagnosed with both a mild traumatic brain injury (mTBI) and post-traumatic stress disorder (PTSD) based on the joint criteria of the Veterans' Affairs and Department of Defense (VA \& DoD).
  • Latest mTBI occurred at least 6 months prior to study enrollment.
  • Attention deficit of 1.5 SD below the mean of the RBANS attention index.
  • Family member or friend that is willing to complete a questionnaire.
  • Access to a home computer, or smartphone with internet access.

Exclusion

  • History of pre-morbid learning disability.
  • History of psychiatric diagnosis sufficiently severe to have resulted in inpatient hospitalization.
  • Neurological disease unrelated to TBI (seizure disorder, stroke).
  • Score \< 90 on National Adult Reading Test (NART).
  • Failure of validity testing on the Test of Memory Malingering (TOMM).
  • Reported alcohol or substance abuse within the past year.
  • Reported involvement in current litigation related to injury.
  • Recent change of medications for seizures, depression, or memory.
  • Currently enrolled in other cognitive therapy that cannot be discontinued.
  • Does not speak English fluently.
  • Not competent to provide consent (also, not able to demonstrate understanding of expectations of study and potential risks of participation).
  • Uncontrolled, acute medical or psychiatric condition as indicated by the participant or observed by the research team member that would make it unsafe to participate in the research activities, i.e. precautions for active homicidal/suicidal intent, active psychosis, or acute symptoms requiring immediate medical attention.

Key Trial Info

Start Date :

November 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 31 2026

Estimated Enrollment :

63 Patients enrolled

Trial Details

Trial ID

NCT05380050

Start Date

November 1 2022

End Date

October 31 2026

Last Update

October 21 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

North Florida/South Georgia Veterans Health System, Gainesville, FL

Gainesville, Florida, United States, 32608-1135